CALABRETTA, Bruno
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 27.493
AS - Asia 12.325
EU - Europa 10.177
SA - Sud America 2.021
AF - Africa 227
Continente sconosciuto - Info sul continente non disponibili 110
OC - Oceania 19
Totale 52.372
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 27.082
GB - Regno Unito 4.101
CN - Cina 3.660
SG - Singapore 3.170
HK - Hong Kong 1.733
BR - Brasile 1.585
VN - Vietnam 1.365
IT - Italia 1.265
SE - Svezia 1.063
DE - Germania 839
UA - Ucraina 699
FI - Finlandia 685
BD - Bangladesh 628
TR - Turchia 454
RU - Federazione Russa 452
FR - Francia 377
KR - Corea 352
BG - Bulgaria 267
IN - India 211
CA - Canada 204
AR - Argentina 163
ID - Indonesia 152
MX - Messico 103
JP - Giappone 101
IQ - Iraq 76
EC - Ecuador 72
NL - Olanda 62
ZA - Sudafrica 58
PL - Polonia 54
CO - Colombia 52
PK - Pakistan 49
VE - Venezuela 48
AT - Austria 44
MA - Marocco 44
AE - Emirati Arabi Uniti 41
IE - Irlanda 41
MY - Malesia 38
BE - Belgio 36
PH - Filippine 34
UZ - Uzbekistan 34
ES - Italia 33
SA - Arabia Saudita 30
EG - Egitto 28
CL - Cile 25
EU - Europa 25
DZ - Algeria 23
LT - Lituania 23
PE - Perù 22
TN - Tunisia 22
AZ - Azerbaigian 21
UY - Uruguay 21
CR - Costa Rica 20
PY - Paraguay 20
CZ - Repubblica Ceca 19
JO - Giordania 19
NP - Nepal 19
PT - Portogallo 19
IR - Iran 17
AU - Australia 14
KE - Kenya 14
TH - Thailandia 14
KZ - Kazakistan 13
OM - Oman 12
CH - Svizzera 11
HN - Honduras 11
JM - Giamaica 11
DO - Repubblica Dominicana 10
PS - Palestinian Territory 10
QA - Qatar 10
RO - Romania 10
BO - Bolivia 9
GT - Guatemala 9
LB - Libano 9
LV - Lettonia 9
BY - Bielorussia 8
KG - Kirghizistan 8
PA - Panama 7
TW - Taiwan 7
AL - Albania 6
ET - Etiopia 6
HU - Ungheria 6
MD - Moldavia 6
RS - Serbia 6
SI - Slovenia 6
SV - El Salvador 6
TT - Trinidad e Tobago 6
AO - Angola 5
BB - Barbados 5
GE - Georgia 5
GR - Grecia 5
IL - Israele 5
PR - Porto Rico 5
SK - Slovacchia (Repubblica Slovacca) 5
A2 - ???statistics.table.value.countryCode.A2??? 4
AM - Armenia 4
BA - Bosnia-Erzegovina 4
CY - Cipro 4
DK - Danimarca 4
EE - Estonia 4
HR - Croazia 4
Totale 52.217
Salva come PNG Salva come JPEG
Città #
Southend 3.067
Fairfield 2.811
Ashburn 2.457
Woodbridge 2.276
Santa Clara 2.081
Singapore 1.956
Hong Kong 1.722
Houston 1.628
Jacksonville 1.543
Hefei 1.303
Ann Arbor 1.133
Chandler 1.095
Cambridge 1.023
Seattle 1.013
Wilmington 1.008
Dearborn 903
Nyköping 746
San Jose 696
London 619
Beijing 593
Ho Chi Minh City 477
The Dalles 426
Modena 424
Helsinki 423
Los Angeles 364
Council Bluffs 357
San Diego 337
Hanoi 326
Seoul 326
New York 288
Princeton 270
Sofia 262
Eugene 250
Chicago 227
Izmir 210
Lauterbourg 208
Buffalo 183
Milan 178
Shanghai 136
São Paulo 134
Columbus 128
Des Moines 125
Moscow 113
Redwood City 102
Dallas 94
Jakarta 93
Falls Church 82
Munich 80
Salt Lake City 79
Da Nang 77
Tokyo 70
Falkenstein 69
Boardman 60
Toronto 60
Haiphong 58
Frankfurt am Main 57
Norwalk 52
Guangzhou 50
Rome 50
Orem 49
North Bergen 48
Phoenix 44
Nanjing 42
Warsaw 41
Dublin 40
Miano 39
Philadelphia 38
Rio de Janeiro 38
Brooklyn 37
Mexico City 37
Denver 36
Atlanta 35
Belo Horizonte 35
Brasília 35
Brussels 34
Kent 34
Nuremberg 34
Tampa 34
Chennai 33
Elk Grove Village 32
Baghdad 31
Johannesburg 30
Curitiba 29
Quito 29
Tashkent 29
Bremen 27
Hounslow 26
Montreal 26
Biên Hòa 25
Dongguan 24
Kilburn 24
Kunming 24
Verona 24
Zhengzhou 24
Hải Dương 23
Porto Alegre 23
Turku 23
Wuhan 23
Amsterdam 22
Boston 22
Totale 38.281
Salva come PNG Salva come JPEG
Nome #
Impact of a single nucleotide polymorphism in the MDM2 gene on neuroblastoma development and aggressiveness: results of a pilot study on 239 patients 448
KLF4 mediates the effect of 5-ASA on the b-catenin pathway in colon cancer cells 416
Enhanced proliferative potential of hematopoietic cells expressing degradation-resistant c-Myb mutants 384
Suppression of invasion and metastasis of triple-negative breast cancer lines by pharmacological or genetic inhibition of slug activity 381
Expression of μ-protocadherin is negatively regulated by the activation of the β-catenin signaling pathway in normal and cancer colorectal enterocytes 375
Elongation factor 1 alpha interacts with phospho-Akt in breast cancer cells and regulates their proliferation, survival and motility 370
Monocyte-macrophage differentiation of acute myeloid leukemia cell lines by small molecules identified through interrogation of the Connectivity Map database 365
Effects of C/EBP alpha and C/EBP beta in BCR/ABL-expressing cells - Differences and similarities 359
BCR/ABL activates mdm2 rnRNA translation via the La antigen 345
ATG7 regulates energy metabolism, differentiation and survival of Philadelphia-chromosome-positive cells 337
Requirement of c-Myb for p210(BCR/ABL)-dependent transformation of hematopoietic progenitors and leukemogenesis 334
Inducible activation of CEBPB, a gene negatively regulated by BCR/ABL, inhibits proliferation and promotes differentiation of BICRABL-expressing cells 330
c-Myb and its target Bmi1 are required for p190BCR/ABL leukemogenesis in mouse and human cells 328
hnRNP A1 nucleocytoplasmic shuttling activity is required for normal myelopoiesis and BCR/ABL leukemogenesis 325
Altered expression of G1 specific genes in human malignant myeloid cells. 321
Gfi-1 inhibits proliferation and colony formation of p210BCR/ABL-expressing cells viatranscriptional repression of STAT 5 and Mcl-1 320
Expression of p89(c-Mybex9b), an alternatively spliced form of c-Myb, is required for proliferation and survival of p210BCR/ABL-expressing cells. 320
Phosphorylation of serine 21 modulates the proliferation inhibitory more than the differentiation inducing effects of C/EBPα in K562 cells. 316
The p53 Codon 72 Pro/Pro Genotype Identifies Poor-Prognosis Neuroblastoma Patients: Correlation with Reduced Apoptosis and Enhanced Senescence by the p53-72P Isoform. 315
Inhibiting interactions of lysine demethylase LSD1 with Snail/Slug blocks cancer cell invasion. 313
A degradation-resistant c-Myb mutant cooperates with Bcl-2 in enhancing proliferative potential and survival of hematopoietic cells 306
Suppression of autophagy by BCR/ABL 306
CDKN2A-independent role of BMI1 in promoting growth and survival of Ph+ acute lymphoblastic leukemia 296
Resistance to apoptosis in CTLL-2 cells constitutively expressing c-Myb is associated with induction of bcl-2 expression and Myb-dependent regulation of bcl-2 promoter activity 295
Expression of CCL9/MIP-1γ is repressed by BCR/ABL and its restoration suppresses in vivo leukemogenesis of 32D-BCR/ABL cells 293
Isolation and functional assessment of common, polymorphic variants of the B-MYB proto-oncogene associated with a reduced cancer risk 291
The transcription activation function of C/EBPalpha is required for induction of granulocytic differentiation 289
Transcriptional repression of c-Myb and GATA-2 is involved in the biologic effects of C/EBPalpha in p210BCR/ABL-expressing cells 289
Expression of Slug Is Regulated by c-Myb and Is Required for Invasion and Bone Marrow Homing of Cancer Cells of Different Origin 289
Coding sequence and intron-exon junctions of the c-myb gene are intact in the chronic phase and blast crisis stages of chronic myeloid leukemia patients 286
Activation of human B-MYB by cyclins. 284
BCR-ABL prevents c-Jun-mediated and proteasome-dependent FUS (TLS) proteolysis through a protein kinase C beta II-dependent pathway 282
Signal transducer and activator of transcription (STAT)5 activation by BCR/ABL is dependent on intact Src homology (SH)3 and SH2 domains of BCR/ABL and is required for leukemogenesis. 280
Physical interaction between CDK9 and B-MYB results in suppression of B-MYB gene autoregulation. 277
BCR-ABL antisense oligodeoxynucleotide in vitro purging and autologous bone marrow transplantation for patients with chronic myelogenous leukemia in advanced phase. 274
The SH3 domain contributes to BCR/ABL-dependent leukemogenesis in vivo: role in adhesion, invasion, and homing. 271
Oligonucleotide N3'-->P5' phosphoramidates as antisense agents. 271
TLS/FUS, a pro-oncogene involved in multiple chromosomal translocations, is a novel regulator of BCR/ABL-mediated leukemogenesis 270
Delivery of c-myb antisense oligodeoxynucleotides to human neuroblastoma cells via disialoganglioside GD(2)-targeted immunoliposomes: antitumor effects 268
Activation of p53-dependent responses in tumor cells treated with a PARC-interacting peptide 268
Cell-cycle-dependent expression of human ornithine decarboxylase. 267
A c-myb antisense oligodeoxynucleotide inhibits normal human hematopoiesis in vitro. 265
Positive autoregulation of c-myb expression via myb binding sites in the 5' flanking region of the human c-myb gene 264
Coding sequence and growth regulation of the human vimentin gene. 264
Targeting autophagy potentiates tyrosine kinase inhibitor–induced cell death in Philadelphia chromosome–positive cells, including primary CML stem cells 264
Inhibition of autophagy: a new strategy to enhance sensitivity of chronic myeloid leukemia stem cells to tyrosine kinase inhibitors 264
Multiple signaling pathways of the insulin-like growth factor 1 receptor in protection from apoptosis. 263
Altered mRNA translation: possible mechanism for CML disease progression. 261
Versatility of BCR/ABL-expressing leukemic cells in circumventing pro-apoptotic BAD effects 258
The transcription factors c-myb and GATA-2 act independently in the regulation of normal hematopoiesis. 258
Regulation of Balb/c3T3 fibroblast proliferation by B-myb is accompanied by selective activation of cdc2 and cyclin D1 expression. 256
Role of pescadillo and upstream binding factor in the proliferation and differentiation of murine myeloid cells 256
Leukemogenesis induced by wild-type and STI571-resistant BCR/ABL is potently suppressed by C/EBPα 255
Regulation of microRNA-145 by growth arrest and differentiation. 255
The Jun family members, c-Jun and JunD, transactivate the human c-myb promoter via an Ap1-like element. 255
Antisense oligodeoxynucleotides for the treatment of chronic myelogenous leukemia: are they still a promise? 254
Antileukemia effect of c-myc N3′→P5′ phosphoramidate antisense oligonucleotides in vivo 251
Antisense myb inhibition of purified erythroid progenitors in development and differentiation is linked to cycling activity and expression of DNA polymerase alpha. 250
B-myb alters the response to myeloid precurson cells to G-CSF 249
Expression of the myeloperoxidase gene in acute and chronic myeloid leukemias: relationship to the expression of cell cycle-related genes. 249
Celecoxib inhibits proliferation and survival of chronic myelogeous leukemia (CML) cells via AMPK-dependent regulation of β-catenin and mTORC1/2 248
Ectopic expression of A-myb in transgenic mice causes follicular hyperplasia and enhanced B lymphocyte proliferation. 246
Targeting CDK6 and BCL2 exploits the "MYB addiction" of Phþ acute lymphoblastic leukemia 246
The biological effects of C/EBPalpha in K562 cells depend on the potency of the N-terminal regulatory region, not on specificity of the DNA binding domain. 245
Molecular cloning of a cDNA for a human ADP/ATP carrier which is growth-regulated. 245
Antisense oligonucleotides. 244
Wild-type p53 differentially affects tumorigenic and metastatic potential of murine metastatic cell variants. 243
A cell proliferation-dependent multiprotein complex NC-3A positively regulates the CD34 promoter via a TCATTT-containing element. 241
BCR-ABL suppresses C/EBP alpha expression through inhibitory action of hnRNP E2 240
Ricerca di markers diagnostici, prognostici e predittivi in carcinomi mammari attraverso analisi proteomica 238
Resistance to apoptosis in CTLL-2 cells overexpressing B-Myb is associated with B-Myb-dependent bcl-2 induction 237
HLA DR associated invariant chain is highly expressed in chronic lymphocytic leukemia. 237
Downregulation of the upstream binding factor1 by glycogen synthase kinase3beta in myeloid cells induced to differentiate. 237
Leukemia stem cells: Old concepts and new perspectives 235
The nucleoside diphosphate kinase activity of DRnm23 is not required for inhibition of differentiation and induction of apoptosis in 32Dcl3 myeloid precursor cells 233
Expression of the Transcriptional Repressor Gfi-1 Is Regulated by C/EBP{alpha} and Is Involved in Its Proliferation and Colony Formation-Inhibitory Effects in p210BCR/ABL-Expressing Cells. 233
Guidelines for the use and interpretation of assays for monitoring autophagy. 233
B-myb promotes S phase and is a downstream target of the negative regulator p107 in human cells. 232
Structural and functional analysis of a growth-regulated gene, the human calcyclin 232
Targeting BCR-ABL-independent TKI resistance in chronic myeloid leukemia by mTOR and autophagy inhibition 232
Direct transactivation of the anti-apoptotic gene Apolipoprotein J (Clusterin) by B-MYB. 231
Activity of tyrosine kinase inhibitor Dasatinib in neuroblastoma cells in vitro and in orthotopic mouse model 231
Tumorigenic conversion of p53 deficient colon epithelial cells by an activated Ki-ras gene 230
Role of p53 in hematopoietic recovery after cytotoxic treatment. 229
Granulocytic differentiation of normal hematopoietic precursor cells induced by transcriptional factor PU.1 correlates with negative regulation of the c-myb promoter. 228
TGF-β-induced c-Myb affects the expression of EMT-associated genes and promotes invasion of ER+ breast cancer cells. 228
Expression of constitutively active Raf-1 in the mitochondria restores antiapoptotic and leukemogenic potential of a transformation-deficient BCR/ABL mutant 228
Structure-based screen identifies a potent small molecule inhibitor of Stat5a/b with therapeutic potential for prostate cancer and chronic myeloid leukemia 228
Translational regulation by the p210 BCR/ABL oncoprotein 226
G1/S transition in normal human T-lymphocytes requires the nuclear protein encoded by c-myb. 225
miRNA let-7c promotes granulocytic differentiation in acute myeloid leukemia. 225
Silencing of endogenous IGFBP-5 by micro RNA interference affects proliferation, apoptosis and differentiation of neuroblastoma cells 224
Activation of mitochondrial Raf-1 is involved in the antiapoptotic effects of Akt. 224
A model of Ph' positive chronic myeloid leukemia-blast crisis cell line growth in immunodeficient SCID mice. 224
Expression of c-myc and induction of DNA synthesis by platelet-poor plasma in human diploid fibroblasts. 224
Leukemia treatment in severe combined immunodeficiency mice by antisense oligodeoxynucleotides targeting cooperating oncogenes. 223
Induction of hematopoietic commitment and erythromyeloid differentiation in embryonal stem cells constitutively expressing c-myb. 223
Different frequency classes of sequences in heterogeneous nuclear RNA of normal promyelocytes and lymphoblasts and of leukemic blast cells of circulating blood and of the HL60 line. 223
Growth regulated expression of B-myb in fibroblasts and hematopoietic cells. 219
An oligomer complementary to c-myb-encoded mRNA inhibits proliferation of human myeloid leukemia cell lines. 219
Totale 27.134
Salva come PNG Salva come JPEG
Categoria #
all - tutte 207.433
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 207.433
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20224.087 85 611 409 248 127 197 274 218 439 272 738 469
2022/20233.287 442 373 245 304 355 528 79 318 416 36 112 79
2023/20241.946 82 126 134 158 502 183 274 187 43 19 53 185
2024/20257.583 210 29 56 482 1.454 1.048 754 441 808 280 838 1.183
2025/202615.965 965 885 1.720 2.086 1.512 1.093 1.876 949 1.336 1.329 1.201 1.013
2026/2027603 603 0 0 0 0 0 0 0 0 0 0 0
Totale 52.372